X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs IPCA LABS - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS IPCA LABS J.B.CHEMICALS/
IPCA LABS
 
P/E (TTM) x 14.2 27.7 51.2% View Chart
P/BV x 2.2 2.1 105.5% View Chart
Dividend Yield % 0.2 0.2 71.5%  

Financials

 J.B.CHEMICALS   IPCA LABS
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
IPCA LABS
Mar-17
J.B.CHEMICALS/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs318643 49.5%   
Low Rs200503 39.7%   
Sales per share (Unadj.) Rs148.0254.4 58.2%  
Earnings per share (Unadj.) Rs19.116.1 118.8%  
Cash flow per share (Unadj.) Rs23.929.8 80.4%  
Dividends per share (Unadj.) Rs0.501.00 50.0%  
Dividend yield (eoy) %0.20.2 110.7%  
Book value per share (Unadj.) Rs128.9194.6 66.3%  
Shares outstanding (eoy) m84.82126.20 67.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.72.3 77.7%   
Avg P/E ratio x13.635.7 38.0%  
P/CF ratio (eoy) x10.819.2 56.2%  
Price / Book Value ratio x2.02.9 68.2%  
Dividend payout %2.66.2 42.1%   
Avg Mkt Cap Rs m21,95172,300 30.4%   
No. of employees `0002.713.3 20.6%   
Total wages/salary Rs m1,8416,960 26.5%   
Avg. sales/employee Rs Th4,590.92,413.5 190.2%   
Avg. wages/employee Rs Th673.4523.2 128.7%   
Avg. net profit/employee Rs Th592.1152.4 388.4%   
INCOME DATA
Net Sales Rs m12,55132,106 39.1%  
Other income Rs m542226 240.0%   
Total revenues Rs m13,09332,332 40.5%   
Gross profit Rs m2,0554,448 46.2%  
Depreciation Rs m4121,730 23.8%   
Interest Rs m96241 39.7%   
Profit before tax Rs m2,0882,703 77.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469675 69.5%   
Profit after tax Rs m1,6192,028 79.8%  
Gross profit margin %16.413.9 118.2%  
Effective tax rate %22.525.0 89.9%   
Net profit margin %12.96.3 204.2%  
BALANCE SHEET DATA
Current assets Rs m7,77817,340 44.9%   
Current liabilities Rs m4,3589,559 45.6%   
Net working cap to sales %27.224.2 112.4%  
Current ratio x1.81.8 98.4%  
Inventory Days Days55100 54.5%  
Debtors Days Days8057 140.7%  
Net fixed assets Rs m5,71320,779 27.5%   
Share capital Rs m170252 67.2%   
"Free" reserves Rs m10,54724,499 43.0%   
Net worth Rs m10,93724,553 44.5%   
Long term debt Rs m03,517 0.0%   
Total assets Rs m15,57439,595 39.3%  
Interest coverage x22.812.2 186.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.8 99.4%   
Return on assets %11.05.7 192.1%  
Return on equity %14.88.3 179.2%  
Return on capital %20.010.5 190.3%  
Exports to sales %48.748.6 100.2%   
Imports to sales %7.114.2 49.7%   
Exports (fob) Rs m6,11515,617 39.2%   
Imports (cif) Rs m8894,571 19.4%   
Fx inflow Rs m6,16915,617 39.5%   
Fx outflow Rs m1,2855,828 22.1%   
Net fx Rs m4,8849,790 49.9%   
CASH FLOW
From Operations Rs m1,3972,764 50.5%  
From Investments Rs m-320-1,432 22.4%  
From Financial Activity Rs m-1,196-1,591 75.1%  
Net Cashflow Rs m-102-259 39.5%  

Share Holding

Indian Promoters % 55.4 45.9 120.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 11.4 29.7%  
FIIs % 3.9 25.3 15.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.4 212.6%  
Shareholders   30,437 36,892 82.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DR. DATSONS LABS  STRIDES SHASUN LTD  FDC LTD.  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare J.B.CHEMICALS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 18, 2017 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - DISHMAN PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS